Literature DB >> 2956747

Anti-atherogenic activity of the calcium channel blocker isradipine (PN-200-110): a novel effect on matrix synthesis independent of calcium channel blockade.

J G Heider, D B Weinstein, C E Pickens, S Lan, C M Su.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2956747

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).

Authors:  R H Grimm; J M Flack; R Byington; G Bond; S Brugger
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.

Authors:  A Fitton; P Benfield
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.